Can erythropoietin be used to prevent brain damage in cerebral malaria?
Erythropoietin (Epo) modulates the survival of developing erythroid cells and the production of new erythrocytes in the bone marrow and is a key molecule in the adaptation to hypoxia and anaemia. Epo receptors have been found to be widely expressed on non-haematopoietic cells, and Epo has been shown...
主要な著者: | Casals-Pascual, C, Idro, R, Picot, S, Roberts, D, Newton, C |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
2009
|
類似資料
-
Erythropoietin and neuro-protection in African children with cerebral malaria
著者:: Idro, R, 等
出版事項: (2008) -
High levels of erythropoietin are associated with protection against neurological sequelae in African children with cerebral malaria.
著者:: Casals-Pascual, C, 等
出版事項: (2008) -
Cerebral malaria: mechanisms of brain injury and strategies for improved neurocognitive outcome.
著者:: Idro, R, 等
出版事項: (2010) -
Pathogenesis, clinical features, and neurological outcome of cerebral malaria.
著者:: Idro, R, 等
出版事項: (2005) -
A better biomarker for cerebral malaria: in the eye of the beheld?*.
著者:: Ackerman, H, 等
出版事項: (2012)